All Articles

New data shows small businesses in overlooked communities are not just adopting tech, but leading the way with AI and crypto out of sheer necessity.

Economic pressure and a thirst for digital convenience are driving Canadians to adopt a 'multi-banking' lifestyle, reshaping the nation's financial landscape.

Oral care brand Boka is now in all 4,500 Walmart stores, marking a major moment for fluoride-free toothpaste and science-backed wellness.

As its novel oral antiviral for the 'winter vomiting bug' enters a pivotal human study, Cocrystal Pharma balances hope with financial prudence.

In a key strategic move, Clear Channel Outdoor partners with Matter Communications to amplify its leadership in an OOH industry transformed by AI and data.

BLUETTI launches its powerful EnergyPro 13K system, offering whole-home backup, massive solar input, and smart features to rival market leaders.

The Polish biotech will showcase its STRIDE® platform at AACR 2026, promising more precise ways to measure cancer's response to therapy.

The fiber provider is challenging giants with ultra-fast internet, free Wi-Fi backup, and aggressive pricing, setting a new standard for home and business users.

With $8M from top VCs, this AI startup built by ex-agents is automating 70% of an agent's day, aiming to revolutionize the insurance industry.

In Las Vegas, Ziebart celebrated record franchise growth and new tech, proving its strength lies in a dual strategy of innovation and a people-first culture.

A renewed multi-year deal extends a two-decade partnership, ensuring 4,000+ credit unions have the stable, modern payment solutions to stay competitive.

With strategic acquisitions and a booming market for fresh meals, Mama's Creations is on an aggressive path to dominate the deli aisle. Can it reach its $1B goal?

A new, non-invasive therapy for men offers a faster, FDA-cleared, and Medicare-covered path to regaining bladder control after prostate surgery at home.

A new, imageable liver cancer therapy is one step closer to patients, thanks to a strategic partnership securing a vital US-based medical isotope supply.

With its new $100M Fund IV, Corazon Capital is doubling down on its operator-led model to back early-stage AI startups focused on amplifying human potential.

A key U.S. patent extends protection for a promising CRPS-1 drug, paving the way for a potential first-in-class treatment for the debilitating condition.

Longhorn Diagnostics unveils LHNVD-501, a novel antibody targeting a universal bacterial component, offering a new front against AMR and chronic inflammation.

Vantage Bank partners with Finzly, leveraging its BankOS platform to bypass legacy systems and enhance its international payment and FX services for clients.

Construction starts on Canada's next-gen polar icebreaker, a project to secure Arctic sovereignty, create jobs, and test a new international shipbuilding model.

Biotech startup Infinimmune's 'human-first' AI platform lands a major deal with Merck, aiming to revolutionize how new antibody drugs are created.